United Kingdom Archives

News and Trends 8 Dec 2017

A London Biotech Aims to Overtake the Dry Eye Syndrome Market

TopiVert has released the results of a clinical trial that the company believes yielded “the best proof of concept data in dry eye syndrome.” Based in London, the biotech company TopiVert is trying to enter the $3Bn market of dry eye syndrome with a drug with the potential to work better than the options currently […]

December 8, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 6 Dec 2017

CRISPR Does it Again! Gene Editing Tool Identifies a New Leukemia Target

Researchers from the Wellcome Trust Sanger Institute have reported that a new target for the treatment of leukemia has been found. A new drug target for acute myeloid leukemia (AML) has been identified that could open new avenues for the development of new treatments against the deadly disease. Researchers from the Wellcome Trust Sanger Institute have […]

December 6, 2017 - 3 minutesmins - By Alex Dale

News and Trends 28 Nov 2017

New Gene Therapy for Parkinson’s will be Developed in the UK

Synpromics and UCL will collaborate to develop a gene therapy to treat Parkinson’s disease that only targets specific neurons involved in the disease. Synpromics, based in Edinburgh, Scotland, is a company focusing on gene control. The biotech has decided to put its technology to use for the development of a gene therapy for Parkinson’s in […]

November 28, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 24 Nov 2017

Let’s Clean Up Our Oceans! New Technique Can Find Even the Tiniest Pieces of Plastic

Current research suggests that we only remove 1% of the plastic waste in our oceans. Thankfully, researchers in the UK have developed a technique to find the rest! Researchers at the University of Warwick, UK, have developed a new and cheap method to find even the smallest bits of plastic that are floating around in […]

November 24, 2017 - 3 minutesmins - By Alex Dale

News and Trends 24 Nov 2017

British SynBio Startup Lands $3.6M for AI-Driven Protein Engineering

LabGenius is using synthetic biology to develop new materials. The funding allows the biotech to set up its own research facility to develop its platform. LabGenius, a new biotech startup based in London, is using artificial intelligence (AI) to drive the development of new materials. This morning, the company has announced that it has received […]

November 24, 2017 - 2 minutesmins - By Alex Dale

Philips consortium cancer angle stilla 1

News and Trends 23 Nov 2017

The EU Gives €6.3M Grant to Anti-Cancer Consortium

The consortium of companies will use the EU’s money to support the development of personalized therapies for breast and rectal cancers. Horizon 2020 is the biggest ever EU Research and Innovation program with almost €80B made available to take exciting science to the market. The initiative has awarded a €6.3M grant to a group of companies brought […]

November 23, 2017 - 2 minutesmins - By Alex Dale

News and Trends 22 Nov 2017

Welsh Scientists Use CRISPR to Engineer Cancer-Killing T cells

Scientists at Cardiff University have used CRISPR/Cas9 genome editing technology to produce highly specific killer T cell receptors. Researchers at Cardiff University have replaced the regular receptors found on T cells with their own, which are geared up to better tracking down and killing cancer cells. The research reported in Blood explained how the group removed receptors that interact with immune cells […]

November 22, 2017 - 3 minutesmins - By Alex Dale

News and Trends 20 Nov 2017

British and German Scientists Chuck Proteins in the Trash to Uncover their Function

Trim-Away removes a protein to uncover its true function, which will support disease research and potentially the development of new therapies. Scientists at the Medical Research Council in the UK and the Max Planck Institute in Germany have discovered Trim-Away, a new technique that can remove a protein from a cell so that its true function can […]

November 20, 2017 - 3 minutesmins - By Alex Dale

News and Trends 17 Nov 2017

British Biotech Gets Ready to Launch a New Antibiotic Drug to Fight Resistance

Update (17/11/2017): Motif Bio will raise up to $20M (€17M) in the form of a loan from US firm Hercules Capital. The funds will be used to fund the pre-commercialization stage of iclaprim, a new antibiotic that is expected to be launched in the US in 2019. Originally published on 04/10/2017 Iclaprim is a new antibiotic […]

November 17, 2017 - 3 minutesmins - By Alex Dale

Interview 16 Nov 2017

Waking Up the Immune System with Luc Dochez, CEO of Tusk Therapeutics

Tusk Therapeutics is developing antibodies to ignite the immune system response against cancer. We spoke with CEO Luc Dochez about Tusk and the oncology field. Tusk Therapeutics, based just north of London, focuses on therapeutic antibodies to boost the immune system in the fight against cancer. The company has been developing a number of candidates […]

November 16, 2017 - 6 minutesmins - By Alex Dale

News and Trends 15 Nov 2017

New British Biotech Receives £3M to Develop Small Molecules that Fight Cancer

NeoPhore, has received investment from Sixth Element Capital to develop small molecules that stimulate the immune system against cancer. Sixth Element Capital has invested £3M (€3.3M) in NeoPhore, a new spin-out from PhoreMost – a drug discovery company based in Cambridge, UK. NeoPhore has been set up to explore small molecules that could be used to stimulate […]

November 15, 2017 - 1 minutemin - By Alex Dale

News and Trends 14 Nov 2017

This British Biotech Could Treat T-Cell Lymphoma without Leaving the Body Unprotected

Autolus has revealed a new strategy to treat T-cell lymphoma without harming healthy, protective T cells. The therapy is expected to start human tests soon. T-cell lymphoma is a form of cancer that affects the cells responsible for protecting our body against infections. Unlike it’s done with cancer types that affect other blood cells, it’s […]

November 14, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

United Kingdom

A London Biotech Aims to Overtake the Dry Eye Syndrome Market

CRISPR Does it Again! Gene Editing Tool Identifies a New Leukemia Target

New Gene Therapy for Parkinson’s will be Developed in the UK

Let’s Clean Up Our Oceans! New Technique Can Find Even the Tiniest Pieces of Plastic

British SynBio Startup Lands $3.6M for AI-Driven Protein Engineering

The EU Gives €6.3M Grant to Anti-Cancer Consortium

Welsh Scientists Use CRISPR to Engineer Cancer-Killing T cells

British and German Scientists Chuck Proteins in the Trash to Uncover their Function

British Biotech Gets Ready to Launch a New Antibiotic Drug to Fight Resistance

Waking Up the Immune System with Luc Dochez, CEO of Tusk Therapeutics

New British Biotech Receives £3M to Develop Small Molecules that Fight Cancer

This British Biotech Could Treat T-Cell Lymphoma without Leaving the Body Unprotected

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!